A Study to Describe Risk Factor and Clinical Outcomes in Patients with Systemic Right Ventricle


  • Study type

  • Study IDs

  • Describes the nature of a clinical study. Types include:

    • Observational study — observes people and measures outcomes without affecting results.
    • Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
    • Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
  • Site IRB
    • Rochester, Minnesota: 17-010889
    Sponsor Protocol Number: 17-010889

About this study

The purpose of the study is to describe risk factor and clinical outcomes in patients with systemic right ventricle.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. If you need assistance understanding the eligibility criteria, please contact the study team.

See eligibility criteria

Inclusion Criteria:

  1. Patients with systemic right ventricle (> 18 years of age) with at least 12 months of follow-up.

Exclusion Criteria: 

  1. Patients without adequate follow-up or cardiovascular testing in the Electronic Health Records.

Participating Mayo Clinic locations

Study statuses change often. Please contact us for help.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Alexander Egbe, M.D., M.B.B.S.

Contact us for the latest status

Contact information:

Alexander Egbe M.D., M.B.B.S.



More information


Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available


Mayo Clinic Footer